期刊全称 | Beta-Blockers in Hypertension and Angina Pectoris | 期刊简称 | Different Compounds, | 影响因子2023 | Ton J. M. Cleophas | 视频video | http://file.papertrans.cn/185/184351/184351.mp4 | 图书封面 |  | 影响因子 | "Knowledge desires increase - it is like fire that first must be kindled by some external agent, but which will always afterward propagate itself". Johnson, Letter to William Drummond August 13, 1776 The therapeutic effectiveness and safety of beta-adrenergic blocking drugs has been well established in patients with essential hypertension and arteriosclerotic cardiovascular disease. These drugs are useful in primary protection against cardiovascular morbidity or mortality in patients with essential hypertension and secondary protection (mor bidity and mortality in patients with myocardial infarction). Although there are mass action effects common to all of beta-adrenergic block ing agents, these agents differ in their effects on the RAS system, beta blockade, norepinephrine release, CNS effects, peripheral vas cular resistance, inotrophic effects, vasomotor effects, and effects on plasma volume. Dr. Ton J. M. Cleophas has addressed this problem of different com pounds and different strategies in the use of beta-adrenergic blockers. In Chapter 1 of this book the author deals with the problem of paradoxical pressor responses from non cardioselective beta blockade. Chapter 2 deals | Pindex | Book 1995 |
The information of publication is updating
|
|